Flagship explainer

How ACADIA PHARMACEUTICALS INC makes its money

Start with a dollar of revenue and follow what the filing says remains.

revenueBranching filed flows with values and percentages directly labeled. Missing filing concepts are omitted rather than estimated.Revenue$1.1B · 100%Cost of revenue$89M · 8%Gross profit$983M · 92%Operating income$105M · 10%Income before tax$139M · 13%Income tax−$252M · −24%Net income$391M · 36%As of 2025-12-31 · 2 SEC filing sourcesBuy Like Buffett · buylikebuffett.com

Honest partial: the filing did not provide a normalized tag for Research and development, Selling, general and administrative; those components are omitted, not plugged.

Table alternative
Filed lineValue% of revenueSource
$1.1B100%
Cost of revenue$89M8%
$983M92%
$105M10%
Income before tax$139M13%
Income tax−$252M−24%
$391M36%
Source: · event Dec 31, 2025 · retrieved Jul 26, 2026 · annual-row source set
Embed this chart

View the full ACADIA PHARMACEUTICALS INC analysis at Buy Like Buffett